Key terms
About TFFP
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TFFP news
Apr 18
5:24pm ET
TFF Pharmaceuticals files to sell 147,500 shares of common stock for holders
Apr 15
7:03am ET
TFF Pharmaceuticals announces data from TFF TAC Phase 2 trial
Apr 08
6:42am ET
TFF Pharmaceuticals files to sell common stock, warrants, no amount given
Apr 04
2:52pm ET
TFF Pharmaceuticals price target lowered to $13 from $25 at JonesResearch
Apr 04
1:20pm ET
Analysts’ Top Healthcare Picks: ADC Therapeutics (ADCT), TFF Pharmaceuticals (TFFP)
Mar 28
4:18pm ET
TFF Pharmaceuticals reports Q4 EPS ($2.01) vs. ($6.13) last year
Mar 28
8:37am ET
TFF Pharmaceuticals price target lowered to $44 from $56 at Roth MKM
Mar 27
4:12pm ET
TFF Pharmaceuticals Shares Key Updates with Investors
Mar 27
4:09pm ET
TFF Pharmaceuticals to present late-breaking abstract/data at ISHLT 2024
Mar 20
12:10pm ET
TFF Pharmaceuticals trading resumes
Mar 20
12:02pm ET
TFF Pharmaceuticals announces $1.2M registered direct offering
Mar 20
12:00pm ET
TFF Pharmaceuticals trading halted, volatility trading pause
Mar 20
9:11am ET
TFF Pharmaceuticals announces update on clinical program
Feb 29
9:39am ET
TFF Pharmaceuticals trading resumes
Feb 29
9:34am ET
TFF Pharmaceuticals trading halted, volatility trading pause
Jan 24
8:14am ET
TFF Pharmaceuticals to present data from its Phase 2 trial of TFF VORI
No recent press releases are available for TFFP
TFFP Financials
Key terms
Ad Feedback
TFFP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TFFP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range